Nilsine Partners, LLC Bristol Myers Squibb CO Transaction History

Nilsine Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$47.98 - $54.4 $21,638 - $24,534	-451 Reduced 4.43%	9,739 $528 Million
Q4 2023 Jan 24, 2024	SELL	$48.48 - $57.85 $11,732 - $13,999	-242 Reduced 2.32%	10,190 $523 Million
Q3 2023 Nov 01, 2023	SELL	$57.89 - $64.73 $31,723 - $35,472	-548 Reduced 4.99%	10,432 $605 Million
Q2 2023 Jul 21, 2023	BUY	$63.71 - $70.74 $26,630 - $29,569	418 Added 3.96%	10,980 $702 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $694,029 - $787,185	10,562 New	10,562 $732 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Nilsine Partners, LLC with notifications on news.